Three people in contact with a hospitalized bird flu patient in Missouri have developed symptoms, officials said.
A third close contact of a patient in Missouri who was hospitalized with H5N1 bird flu has reported that they also experienced symptoms, the US Centers for Disease Control and Prevention said Friday.
Health officials identified three contacts, including two healthcare workers, who were closely monitored after a bird flu ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
The number of people who were in contact with the hospitalized bird flu patient in Missouri and developed symptoms is now up ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
A second health worker in contact with the Missouri patient who tested positive for bird flu also developed symptoms but wasn ...
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
A second health worker who cared for a person hospitalized in Missouri with H5N1 bird flu developed mild respiratory symptoms ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
T he first-ever needleless flu vaccine that can be given at home was just approved by the U.S. Food and Drug Administration.
Thus far, the outbreak is growing slowly, says Yale SOM’s Dr. Howard Forman. But a lack of coordination and testing continues ...